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eSoon after the introduction of coronary angioplasty,
it became evident that many of the arteries that had
been opened would eventually re-narrow, and the
therapeutic benefit would be lost. This restenosing
of the vessel was caused by a process of elastic recoil
after the balloon inflation, accompanied by new
tissue growth and constriction of the vessel as part
of the healing phase. With the introduction of
coronary stents, the elastic recoil and chronic con-
striction were largely eliminated, and the remaining
feature of restenosis was the development of neo-
intimal tissue. The introduction of drug-eluting
See page 1002
stents was aimed at combating this remaining
process of restenosis. In an effort to understand the
restenosis process, animal models have been cre-
ated, and among those with physical dimensions
matching human arteries, the porcine model has
become the most widely studied. The initial angio-
plasty model involved overstretch with balloons,
resulting in disruption of the internal elastic lamina,
which uniformly led to a significant neointimal
formation over the next 30 days, being most pro-
nounced in the zone of the disrupted internal elastic
lamina (1). This severe injury was selected because,
in the human procedure in atherosclerotic vessels,
the inflated balloon vastly exceeds the pre-
procedural lumen diameter, and the splitting and
disruption of the vessel are well-known mechanisms
by which the artery is expanded. With the intro-
duction of stents, the porcine model has continued
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ealing process in a favorable direction (2). Balloon
verstretch prior to stenting disrupts the internal
lastic lamina and results in a more effusive healing
esponse than placing a stent without such vascular
amage.
The purpose of studying animal models of reste-
osis and vascular healing is to anticipate like
esponses in patients. As vascular brachytherapy,
nd subsequently, drug-eluting stents, were intro-
uced, the porcine model played a major role in
stablishing that these measures could modify the
ealing response and likely diminish the incidence of
emodynamically significant re-narrowing of the
rtery. In order to study various modifications of the
ealing response, the amount of neointima gener-
ted has been used as a continuous variable in order
o achieve statistical power with limited numbers of
xperimental animals. A similar approach has been
sed in clinical trials where the angiographic late
oss of lumen diameter as judged angiographically
as been used as a surrogate for important clinical
vents. Despite the fact that late loss is thought to
orrelate well with restenosis propensity, how it
elates to measures of neointimal formation remains
ncompletely understood. Although late loss has
ained an exalted status in evaluating the effective-
ess of drug-eluting stents, the true clinical corre-
ate should be excessive late loss that would create a
emodynamically significant obstruction. With the
dvent of drug-eluting stents, the formation of
eointimal tissue is now viewed as both a negative
nd a positive feature of the late outcome. While
triving for the maximum inhibition of neointimal
issue growth and the least angiographic late loss, it
ecame evident that complete inhibition of neoin-
imal tissue formation would leave stent struts
xposed and potentially create a prothrombotic
nvironment. In an effort to balance adequate heal-
ng and coverage of stent struts with inhibition of
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1012excessive tissue growth, it is appropriate to try to
understand the effect of stenting on those outcomes.
An important question is how does the angio-
graphic late loss correlate with tissue elaboration
and avoidance of exposed stent struts?
The present study by Kim et al. (3) examines
both questions: 1) how well angiographic late loss
predicts neointimal proliferation after stenting in a
porcine model of restenosis; and 2) whether it can
also predict stent strut coverage/endothelialization
within stents. Kim et al. performed coronary stent-
ing in 49 domestic swine using drug-eluting and
bare-metal stents, and followed them for 28 to 90
days for the development of neointimal prolifera-
tion and tissue coverage of stent struts. Angiograms
were performed, and the late loss was compared
with neointimal thickening by optical coherence
tomography (OCT) and also by histology. Approx-
imately 7 segments per stent were matched between
the 3 assessment methods, resulting in a total of 382
angiographic segments studied.
Late loss and measures of neointimal formation. The
mean late loss for all stent implants was 0.60 mm,
ranging from 0.46 mm to 2.3 mm. The authors
found good correlation between late loss and neo-
intimal thickness when late loss was 0.55 mm but
poor correlation when late loss was less than that.
The conclusion, therefore, was “angiographic late
loss below a threshold value of 0.55 mm correlates
poorly with [neointimal thickness] obtained by
OCT and histology.” Since most commercially
available drug-eluting stents have late loss measure-
ments that are 0.55 mm, one implication might
be that the amount of neointimal tissue elaborated
and the degree of coverage of stents might be
imprecisely measured by that late loss finding.
Although it is tempting to make such a conclu-
sion, there are a number of differences between this
porcine coronary model and the human condition.
In this porcine model, the stent was placed without
prior overstretch injury to the vessel, with a stent-
to-vessel ratio above 1:1.1, but in most cases, likely
not disrupting the internal elastic lamina. The
authors point out that the neointimal proliferation
was relatively uniform inside the stent circumfer-
ence (3). Neointimal tissue developing inside stents,
especially drug-eluting stents in humans, is often
not uniform. Some of the difficulties in correlating
measurements obtained by angiography, OCT, and
histology should be mentioned. Whereas attempts
were made to avoid foreshortening, the angio-
graphic image chosen was a single projection result-
ing in a 1-dimensional measurement. OCT andhistology, on the other hand, measure a
2-dimensional circular structure. The very similar
degree of neointimal formation seen by OCT and
histology is interesting. The ability to have in vivo
measurements obtained by OCT correlate so pre-
cisely with postmortem histology is worthwhile.
Since this is a stented artery, postmortem shrinkage
of the specimens is obviated. OCT appears to be a
more precise method to measure the effectiveness of
drug-eluting stents in preventing neointimal forma-
tion.
Late loss, strut coverage, and OCT. Another impor-
ant issue relates to whether late loss also can
redict neointimal coverage of stent struts, which at
east, according to pathological studies, is thought
o be a good surrogate for endothelialization. Late
oss when it was 0.55 mm did ensure that almost
ll stent struts were covered by tissue; however,
elow that level, the correlation between angio-
raphic late loss and neointimal formation was not
dequate. When stent strut coverage was consid-
red, the definition used for the OCT measure-
ents was tissue measuring at least 20 m in
thickness overlying the stent struts. The late loss
group below 0.55 mm exhibited 22% uncovered
stents as judged by this OCT criteria. On the other
hand, when stent coverage was measured with
histological examination, virtually all stent struts
(98.3%) were covered. This finding raises the im-
portant question of whether this OCT evaluation of
stent coverage is accurate. It has been shown that
patients dying from stent thrombosis frequently
have uncovered stent struts. On the other hand,
many living patients whose stents are not embedded
in the arterial wall seem to be free of stent throm-
bosis even though current invasive measures cannot
demonstrate neointimal tissue covering these stent
struts. Could part of the paradox be the inability of
OCT to accurately reflect very thin neointimal
coverage of stent struts? This disparity between
OCT measures and histology, although not empha-
sized in the paper, seems to be one of the more
interesting contributions to this investigation.
Conversely, the lack of correlation between mild
degrees of late loss and the degree of neointimal
proliferation in this model is less surprising. In
our laboratory, we typically have not performed
intravascular ultrasound or OCT imaging prior to
terminating the animals. These procedures have
been avoided so as not to compromise the histo-
logical examination, especially as it relates to
stent coverage. However, second-generation
OCT or optical frequency domain imaging has
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1013shown great promise in obtaining images reflect-
ing stent coverage and even discriminating be-
tween cellular tissue and fibrin coverage (4).
Since the model does not generate the same injury
or healing response as is seen in human atherosclero-
sis, it should be questioned as to how this late loss can
predict the degree of neointimal formation in patients.
Also, the concentration on late loss as a proper
surrogate for predicting clinical events should remain
in question. It has never been all about late loss, butJ Am Coll Cardiol 1992;20:467–74.
3
4
of stent healing: comnamic compromise that correlates with clinical events.
Systems of treating obstructive coronary atherosclero-
sis that result in moderate but stable neointimal tissue
with a lumen capable of conducting maximum coro-
nary flow should be the goal of invasive measures of
the future.
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